Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

Thumbnail for Rural-Urban Disparities in Leukemia Mortality Trends Among Young Adults Aged 15-34: A CDC Wonder Analysis (1999-2024)

AML - 398

Rural-Urban Disparities in Leukemia Mortality Trends Among Young Adults Aged 15-34: A CDC Wonder Analysis (1999-2024)

Madho Mal

Poster Presenter: Madho Mal

Thumbnail for Declining but Unequal: Trends and Sociodemographic Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018-2024

AML - 402

Declining but Unequal: Trends and Sociodemographic Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018-2024

Priscilla Kabutey

Poster Presenter: Priscilla Kabutey

Thumbnail for Early vs Late Granulocyte Colony-Stimulating Factor Initiation and Hospital Length of Stay in Adult Inpatients With Severe Neutropenia: A Retrospective Cohort Study

Previous 1...14 15 16 17 18 19 20...26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 409

Early vs Late Granulocyte Colony-Stimulating Factor Initiation and Hospital Length of Stay in Adult Inpatients With Severe Neutropenia: A Retrospective Cohort Study

Ramyar Abdullah

Poster Presenter: Ramyar Abdullah

$Thumbnail for Menin Inhibitors vs FLT3 Inhibitor-Based Therapy in NPM1-Mutated Relapsed/Refractory AML: Comparative Efficacy, MRD Depth, and Safety Profiles$

AML - 414

Menin Inhibitors vs FLT3 Inhibitor-Based Therapy in NPM1-Mutated Relapsed/Refractory AML: Comparative Efficacy, MRD Depth, and Safety Profiles

Hashem Haj Ebrahimi

Poster Presenter: Hashem Haj Ebrahimi

Thumbnail for Dual Targeting of FLT3 Signaling and BCL2 Dependency by Venetoclax in ATO-Resistant FLT3-ITD Acute Promyelocytic Leukemia

AML - 424

Dual Targeting of FLT3 Signaling and BCL2 Dependency by Venetoclax in ATO-Resistant FLT3-ITD Acute Promyelocytic Leukemia

Deepshikha Dutta

Poster Presenter: Deepshikha Dutta

Thumbnail for Persistent DNMT3A Mutations Predicting Relapse After Acute Myeloid Leukemia Remission: A Systematic Review of Molecular Persistence and Circulating DNA Dynamics

AML - 454

Persistent DNMT3A Mutations Predicting Relapse After Acute Myeloid Leukemia Remission: A Systematic Review of Molecular Persistence and Circulating DNA Dynamics

Sahar Amjad

Poster Presenter: Sahar Amjad

Thumbnail for Long-term follow-up of Oral Decitabine/Cedazuridine (ASTX727) Plus Venetoclax in Older or Unfit patients with Newly Diagnosed Acute Myeloid Leukemia

AML - 460

Long-term follow-up of Oral Decitabine/Cedazuridine (ASTX727) Plus Venetoclax in Older or Unfit patients with Newly Diagnosed Acute Myeloid Leukemia

Thura Win Htut

Poster Presenter: Thura Win Htut

Thumbnail for Induction Regimens and Responses in Acute Myeloid Leukemia: Data From a Low- and Middle-Income Country

AML - 464

Induction Regimens and Responses in Acute Myeloid Leukemia: Data From a Low- and Middle-Income Country

Zaigam Ismail

Poster Presenter: Zaigam Ismail

Thumbnail for DNMT3A Co-Mutation and Immune Exclusion Signatures Define Outcomes in AML With IDH2 Mutations

AML - 468

DNMT3A Co-Mutation and Immune Exclusion Signatures Define Outcomes in AML With IDH2 Mutations

Feng-Ming Tien

Poster Presenter: Feng-Ming Tien

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors